These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 30938215

  • 21. Quantification and biodistribution of iron oxide nanoparticles in the primary clearance organs of mice using T1 contrast for heating.
    Zhang J, Ring HL, Hurley KR, Shao Q, Carlson CS, Idiyatullin D, Manuchehrabadi N, Hoopes PJ, Haynes CL, Bischof JC, Garwood M.
    Magn Reson Med; 2017 Aug; 78(2):702-712. PubMed ID: 27667655
    [Abstract] [Full Text] [Related]

  • 22. Fabrication of contrast agents for magnetic resonance imaging from polymer-brush-afforded iron oxide magnetic nanoparticles prepared by surface-initiated living radical polymerization.
    Ohno K, Mori C, Akashi T, Yoshida S, Tago Y, Tsujii Y, Tabata Y.
    Biomacromolecules; 2013 Oct 14; 14(10):3453-62. PubMed ID: 23957585
    [Abstract] [Full Text] [Related]

  • 23. IGF1 Receptor Targeted Theranostic Nanoparticles for Targeted and Image-Guided Therapy of Pancreatic Cancer.
    Zhou H, Qian W, Uckun FM, Wang L, Wang YA, Chen H, Kooby D, Yu Q, Lipowska M, Staley CA, Mao H, Yang L.
    ACS Nano; 2015 Aug 25; 9(8):7976-91. PubMed ID: 26242412
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Iron supplementation and erythropoiesis-stimulatory agents in the treatment of cancer anemia.
    Pedrazzoli P, Rosti G, Secondino S, Siena S.
    Cancer; 2009 Mar 15; 115(6):1169-73. PubMed ID: 19152436
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. PEGylated fullerene/iron oxide nanocomposites for photodynamic therapy, targeted drug delivery and MR imaging.
    Shi J, Yu X, Wang L, Liu Y, Gao J, Zhang J, Ma R, Liu R, Zhang Z.
    Biomaterials; 2013 Dec 15; 34(37):9666-77. PubMed ID: 24034498
    [Abstract] [Full Text] [Related]

  • 31. Antibody-mediated targeting of iron oxide nanoparticles to the folate receptor alpha increases tumor cell association in vitro and in vivo.
    Ndong C, Toraya-Brown S, Kekalo K, Baker I, Gerngross TU, Fiering SN, Griswold KE.
    Int J Nanomedicine; 2015 Dec 15; 10():2595-617. PubMed ID: 25878495
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Magnetic brain tumor targeting and biodistribution of long-circulating PEG-modified, cross-linked starch-coated iron oxide nanoparticles.
    Cole AJ, David AE, Wang J, Galbán CJ, Yang VC.
    Biomaterials; 2011 Sep 15; 32(26):6291-301. PubMed ID: 21684593
    [Abstract] [Full Text] [Related]

  • 36. [Iron supplementation in chronic kidney disease].
    Graczyk M, Dylewska M.
    Wiad Lek; 2017 Sep 15; 70(6 pt 2):1215-1218. PubMed ID: 29533917
    [Abstract] [Full Text] [Related]

  • 37. Activatable fluorescence imaging of macrophages in atherosclerotic plaques using iron oxide nanoparticles conjugated with indocyanine green.
    Ikeda H, Ishii A, Sano K, Chihara H, Arai D, Abekura Y, Nishi H, Ono M, Saji H, Miyamoto S.
    Atherosclerosis; 2018 Aug 15; 275():1-10. PubMed ID: 29852399
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.